| Literature DB >> 25362470 |
Amelia Trimarco1, Maria Grazia Forese1, Valentina Alfieri1, Alessandra Lucente1, Paola Brambilla1, Giorgia Dina1, Damiana Pieragostino2, Paolo Sacchetta2, Yoshihiro Urade3, Brigitte Boizet-Bonhoure4, Filippo Martinelli Boneschi1, Angelo Quattrini1, Carla Taveggia1.
Abstract
Neuregulin 1 type III is processed following regulated intramembrane proteolysis, which allows communication from the plasma membrane to the nucleus. We found that the intracellular domain of neuregulin 1 type III upregulated the prostaglandin D2 synthase (L-pgds, also known as Ptgds) gene, which, together with the G protein-coupled receptor Gpr44, forms a previously unknown pathway in PNS myelination. Neuronal L-PGDS is secreted and produces the PGD2 prostanoid, a ligand of Gpr44. We found that mice lacking L-PGDS were hypomyelinated. Consistent with this, specific inhibition of L-PGDS activity impaired in vitro myelination and caused myelin damage. Furthermore, in vivo ablation and in vitro knockdown of glial Gpr44 impaired myelination. Finally, we identified Nfatc4, a key transcription factor for myelination, as one of the downstream effectors of PGD2 activity in Schwann cells. Thus, L-PGDS and Gpr44 are previously unknown components of an axo-glial interaction that controls PNS myelination and possibly myelin maintenance.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25362470 DOI: 10.1038/nn.3857
Source DB: PubMed Journal: Nat Neurosci ISSN: 1097-6256 Impact factor: 24.884